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Abstract
Magnetic resonance imaging (MRI) has proved to be an ideal modality for non-destructive and highly detailed assessment
of structural morphology in biological tissues. Here we used MRI to make a dataset of ex vivo brains from two different
rodent models of Huntington’s disease (HD), the R6/2 line and the YAC 128 mouse. We are making the whole dataset (399
transgenic HD and wildtype (WT) brains, from mice aged 9–80 weeks) publicly available. These data will be useful, not only
to investigators interested in the study of HD, but also to researchers of computational neuroanatomy who may not have
access to such large datasets from mouse models. Here we demonstrate a number of uses of such data, for example to
produce maps of grey and white matter and cortical thickness. As an example of how the library might provide insights in
mouse models of HD, we calculated whole brain grey matter volumes across different age groups with different numbers of
cytosine-adenine-guanine (CAG) repeats in a fragment of the gene responsible for HD in humans. (The R6/2 dataset was
obtained from an allelic series of R6/2 mice carrying a range of CAG repeat lengths between 109 and 464.) This analysis
revealed different trajectories for each fragment length. In particular there was a gradient of decreasing pathology with
longer CAG repeat lengths, reflecting our previous findings with behavioural and histological studies. There will be no
constraints placed on the use of the datasets included here. The original data will be easily and permanently accessible via
the University of Cambridge data repository (http://www.dspace.cam.ac.uk/handle/1810/243361).
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Introduction
Huntington’s disease (HD) is an inherited, fatal, autosomal
dominant disease characterised by movement disorder and
psychiatric symptoms [1]. The disease results from a repeated
polyglutamine expansion in the coding region of the HTT gene.
There is no cure for HD and there are few effective treatments. A
large number of transgenic mouse models of HD have been
developed to study pathogenesis and investigate potential treat-
ments; the most widely used of these is the R6/2 mouse model that
typically carries a CAG repeat length of 110–250 [2]. This
fragment mouse model shows a progressive phenotype that
recapitulates a number of features of the human condition
including motor disturbances, stereotypic movements, weight loss
and cognitive abnormalities [3–5]. As in the human disease, CAG
repeat lengths appear to be associated with disease onset and
severity [6]. However, mice with extreme repeat lengths in this
model present with a disease having a delayed phenotype. This
delay in the onset and reduction in the severity of symptoms, in
parallel with neurodegenerative changes, provides a model with
the potential to elucidate more of the underlying pathogenesis [7].
In addition to the R6/2 model, a number of other models have
been made that were aimed at recapitulating better the genetics of
HD. These include full length knock-in models [8,9], a yeast
artificial chromosome (YAC128) model [6], and a bacterial
artificial chromosome (BAC) model [10].
Historically, magnetic resonance imaging (MRI) findings for
individual patients were diagnostic only in later stages of HD,
for example where caudate atrophy contributed to the
characteristically large ventricles seen [11]. More recently,
analytical methodologies, such as tensor-based morphometry
(TBM), have been used to show progressive structural changes
in presymptomatic HD patients [12]. Neuroimaging studies
based on voxel-based morphometry (VBM) are also used widely
to investigate developing pathology in humans and assess
prospective treatments [13–18]. These automated methods for
characterising structural differences or changes in the living
brain have also been used in mouse models to show that many
pathological features are shared between the mouse models and
humans with the disease [19–22].
Here we describe a large dataset of MR images of mice used in
models of HD that includes transgenic R6/2 lines of various CAG
expansion lengths, yeast artificial chromosome (YAC128) [23] and
wildtype (WT) mice. In addition, we include the MRI data sets
from a colony of complexin 1 knockout (Cplx1 KO) mice that
showed subtle morphological abnormalities detectable with MRI
[24] that reflect behavioural abnormalities seen in the mice [25].
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We have recently published two studies using a small subset of
these brains (n = 88), where we used manual volumetry and VBM
to characterise differences between WT and R6/2 mice [20,21]. A
novel aspect of that work was the use of segmented grey matter
(GM) and white matter (WM) in the mouse brain, an approach
that is not widely used outside the human brain, despite its success
in patients and healthy controls. The most common alternative
approach to automated analysis involves ignoring the images once
they have been registered to a common atlas and instead
performing statistical tests on the registration parameters (tensor-
or deformation-based morphometry, see e.g. [26,27]). Retaining
some image intensity information in the form of GM maps allows
greater scope for chemical changes that are not associated with
volume changes to be observed. Using measures of shape change
to compare brains, such as the Jacobian determinant of trans-
formation fields, will reveal only microstructural changes when
these cause the registration model to geometrically warp the brain
to ‘correct’ the differences in signal as a geometric change rather
than one in chemical environment. This is particularly relevant
here, as we have shown that not only are there size differences in
key brain regions of the R6/2 mouse, but also signal intensity
changes [21].
We are releasing these datasets to the neuroscience community
to facilitate research into structural differences seen in mice and to
provide common datasets that can be used for advancing
methodological techniques of automated assessment of structural
phenotypes. We are also releasing online the structural data,
segmented GM and WM tissue maps for each brain, as well as
population-average templates that can be used for VBM
investigations [27]. To show how these data might be used, here
we present sample results from automated whole brain volume
assessment across ages in WT mice and sub-strains of R6/2 mice
with differing cytosine-adenine-guanine (CAG) repeat lengths, as
well as brains from YAC128 and complexin 1 knockout (Cplx1
KO) mice. In addition, we present maps showing the cortical
thickness variation between strains. All of the datasets are available
via DSpace, the Institutional Repository of the University of
Cambridge (permanent link: http://www.dspace.cam.ac.uk/
handle/1810/243361). Once lodged, files will remain accessible
indefinitely. As well as the images, metadata describing the age,
sex, and other relevant model details (e.g. for R6/2 mice the CAG
expansion length) will be included. In addition to the image data,
we have provided templates and open-source extension software
(SPMMouse; http://www.spmmouse.com) permitting the analysis
of these and other animal brains in the popular SPM package that
is widely used throughout the neuroimaging community (Well-
come Trust Centre for Neuroimaging, University College London,
UK).
We are continuing to acquire images, in particular from
longitudinal scans acquired in vivo. These will be added to our
open-access library ad hoc as they become available. All of the
datasets presented here were acquired post mortem either as an




All experiments were conducted in accordance with the UK
Animals (Scientific Procedures) Act 1986, and with the approval of
the University of Cambridge Licence Review Committee.
Mice were taken from colonies of R6/2, YAC128 and Cplx1
KO mice established in the University of Cambridge. Mice were
kept from weaning in home cages comprising single sex, single
genotype groups of 10. All of the mice lived in an enhanced
environment with increased amounts of bedding and nestling
materials. Clean cages were provided twice weekly, with grade 8/
10-corncob bedding, and finely shredded paper for nesting.
Genotyping was performed using PCR from tail snips taken at 3
weeks and CAG repeat lengths were measured by Laragen (Los
Angeles, CA,USA). The mice were maintained on a 12 hour light :
12 hour dark cycle with humidity regulated to 55610% and
temperature from 21–23uC. The mice had ad libitum access to
water (using water bottles with elongated spouts) and dry
laboratory food (RM3(E) rodent pellets, Special Diet Services,
Witham, UK). In addition, once a day, a mash was prepared by
soaking 100g dry food in 230 ml water until the pellets were soft
and fully expanded. The mash was placed on the cage floor,
improving access to food and water for the mice. This feeding
regime has been shown previously to be beneficial for R6/2 mice
[28] and so has become standard practice for all of our mouse
colonies.
R6/2 mice [2] were maintained by backcrossing them onto
CBAxC57Bl/6 F1 female mice. Genotyping and CAG repeat
length measurement were carried out by Laragen (Los Angeles,
CA, USA). R6/2 mice were divided into groups according to
CAG repeat length. (Table 1).
YAC128 mice [6] were maintained on a C57/Bl6 background
and genotyped by Laragen (Los Angeles, CA, USA).
Cplx1 KO mice [29] were bred on a mixed genetic background
(129Ola6C57/Bl6) in a colony established in the Department of
Pharmacology, University of Cambridge.
Table 1 shows numbers, sex, genotype and CAG repeat lengths
for all mice used in this study. Table 2 shows the breakdown by
genotype and age of all mice used in this experiment.
Brain Preparation
Mice were deeply anaesthetised with Euthatal, then perfused
with 200 ml ice-cold PBS and fixed with 300 ml of ice-cold
paraformaldehyde (2% in PBS). In our initial protocol, brains were
Table 1. Number of mice in library by genotype and sex.
CAG repeat length Sex
Mouse strain Range Mean SD Male Female
n n n
WT (in-skull) 124 2 2 2 62 62
WT (ex-skull)61 2 2 2 40 21
R6/2 (in-
skull)
Super short 25 109–114 112 1.4 15 10
Short 8 182–187 185 1.5 3 5
Medium 43 224–299 255 15 13 30
Long 21 305–391 353 29 12 9
Super long 15 459–464 461 2.1 4 11
R6/2 ex-skull
Medium 62 230–257 250 3.3 27 35
All R6/2 174 109–464 74 100
YAC 22 9 13
Cplx1 KO 18 8 10
All brains 399 193 206
doi:10.1371/journal.pone.0053361.t001
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extracted from the skull and post-fixed overnight in 2% para-
formaldehyde and cryoprotected in 30% sucrose in PBS (plus
0.02% sodium azide) for 2 days. We refined this protocol for
imaging inside the skull to protect the brain tissues, in particular,
the pial surface and olfactory bulbs. The earliest acquisitions made
were performed with the skull removed so that a smaller solenoid
coil could be used for better image quality. We became concerned,
however, that damage to the brain that could occur during
extraction (in particular to the cortical surface) could limit our
ability to detect subtle differences in these regions. All later
acquisitions were therefore scanned with the skull intact. Full
details of the preparation of the mice used in the construction of
the library are shown in tables 1 and 2.
Image Acquisition
We followed protocols designed for optimal contrast between
grey and white matter. The selected schemes for in-skull and out-
of-skull imaging are described below.
In-skull imaging. Brains were scanned using a 4.7T Bruker
PharmaScan system using a 20cm birdcage coil for transmission
and reception. A rapid acquisition with relaxation enhancement
(RARE) sequence was used (repetition time (TR)/echo time (TE)
2000/30 ms, echo train length (ETL) 8, number of excitations
(NEX) 2) total scan time 3.5 hours per brain. The imaging matrix
was 25661926128 over a field of view 17.9613.469.0 mm3
yielding an isotropic resolution of 70mm3.
Ex-skull imaging. Brains were scanned in Fluorinert FC-77
(3 M), a proton-free susceptibility-matching fluid, using a 1T
Bruker system (Bruker Corporation, Ettlingen, Germany) with
a 13 mm solenoid coil for signal transmission and reception. A
RARE sequence was used for acquisition, optimised for contrast
between GM and WM (TR/TE 2000/50.5 ms, ETL 4, NEX 4),
and giving a total scan time 13.5 hours per brain. The field of view
and matrix parameters were the same as for the in-skull protocol.
Post-processing
All images were reconstructed and stored in NIFTI format
(Neuroimaging Informatics Technology Initiative: http://nifti.
nimh.nih.gov/). Header matrices were updated for rigid alignment
approximately to Paxinos coordinates [30] by manual alignment
to the tissue probability maps (TPMs) created in our previous
VBM study [20]. Specifically, the NIFTI headers of the MRI files
contain a coordinate transformation matrix that maps voxel
coordinates to approximate bregma in millimetres with a rigid
transformation. This was done by visual comparison of landmarks
between the atlases to align the origin of the mapped coordinate
system to bregma points in the Paxinos atlas. Storing this matrix in
the header (without modifying the original data) avoids excessive
interpolation which could degrade image quality for subsequent
processing steps.
Canonical Tissue Class Maps
SPM5 (Wellcome Trust Centre for Neuroimaging, UK) with the
SPMMouse toolbox (http://www.wbic.cam.ac.uk/˜sjs80/
spmmouse.html) was used for affine registration followed by
non-linear registration, radiofrequency inhomogeneity correction
and segmentation based on prior knowledge using the unified
segmentation model [31]. The priors used were those of our
previous VBM study. The resulting modulated maps of GM, WM
and CSF were averaged to produce new probability maps and the
process was repeated. These processing steps were performed
separately for in- and out-of-skull brains due to the differences in
shape between them. For each brain, we provide the native space
image, the native space segmented GM and WM images and the
modulated normalised images in template space.
Voxel-based Cortical Thickness Maps
Maps of cortical thickness for each brain were prepared by first
delineating the cortical hemispheres on the atlas image. Thick-
nesses were evaluated by solving Laplace’s equation with potential
boundaries on the internal and external cortical surfaces with
a ‘resistive’ region for part of the medial cortical boundary
following Lerch et al. [19] as illustrated in Figure 1. The cortical
regions were transformed via non-linear registration to the native
space of each image. In this space the equation was solved to
calculate the potential. At each voxel located in the cortex,
integration is done in rising and falling directions to reach the
inner and outer cortical surfaces, respectively. The sum of these
integrals then gives the cortical thickness measure at that point.
These maps were then transformed back to the common
stereotactic space.
Methods for performing similar calculations have been used in
a number of analyses to date where comparisons have been made
to histological and manual measurements (e.g. [32,33]). In
illustration here, a single brain from the library of data here was
the subject of detailed measurements in two sections in a three-way
comparison of 25 areas of cortex between a manual histological
measurement, a manual measurement based on the native-space
MR image and the calculated cortical thickness map. Details of the
preparation for histology followed our previous protocol [24] and
manual measurements were made by a single reviewer on
homologous cortical features based on the nearest corresponding
points on the MRI slices and histology. The automated
measurements corresponding to each of these were given by
interpolating the start and end points of the lines drawn to
measure the MRI slices.
Accessing the Data
Datasets can be downloaded from http://dspace.cam.ac.uk/
handle/1810/243361. Nifti files can be visualized in every modern
medical imaging package (e.g. freely-available ImageJ, US
National Institutes of Health, Bethesda http://rsbweb.nih.gov/
ij/). Structural analysis of GM/WM can be performed in SPM
with our SPMMouse plugin both of which can be freely
downloaded from the SPM website (http://fil.ion.ucl.ac.uk; Well-
come Trust Centre for Neuroimaging, University College London,
UK).
Table 2. Number of mice in library by genotype and age.
Genotype or strain (n)
Age
(weeks) WT R6/2 YAC Cplx1 KO
Total
number
9–12 9 10 2 2 19
12–15 71 80 2 2 151
15–18 7 3 2 2 10
18–22 58 73 2 2 131
30–45 3 8 2 5 16
45–55 32 2 22 54
55–80 5 13 18
Total 185 174 22 18 399
doi:10.1371/journal.pone.0053361.t002
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Results
Exemplar brain images are shown in Figure 2 for both in-skull
and out-of-skull brains. These particular examples show 18 week-
old out-of-skull images from WT (Figure 2, column A) and R6/2
CAG250 (Figure 2, column B). Figure 2 column C shows our atlas
image constructed from out-of-skull brains. In-skull images are
shown from 22 week old WT and R6/2 CAG250 mice (Figure 2
columns D and E, respectively), and from a 45 week old YAC128
mouse (Figure 2, column F).
Examples of the processed data incorporated into our mouse
library are shown in Figure 3. For illustration, images from raw
data (Figure 3A), GM segmentation (Figure 3B), WM segmenta-
tion (Figure 3C) and cortical thickness maps (Figure 3D) are
shown.
The segmented tissue maps can be used readily to calculate
gross morphological metrics from each brain. For example Figure 4
shows total GM volume for WT brains, with R6/2 (CAG100–
200), (CAG200–300) and (CAG300–400) mice for comparison. If
deviation from WT GM volume is considered to be a crude metric
of disease burden, it can be seen that mice with longer CAG
repeats show a less severe form of disease for comparable age
points in the R6/2 lines. These data are consistent with our
histopathological findings and behavioural/cognitive data [7]. For
completeness, graphs for YAC and Cplx1 KO brains are also
shown. To aid comparison, the least-squares line for the WT series
has been replicated on each panel, together with dashed lines
above and below both shown at twice the standard deviation of the
residuals of WT brains to the linear fit.
As an example of possible uses of the datasets, cortical thickness
maps, reconstructed as 3D brain models in Figure 5, show
thinning in R6/2 with shorter repeat lengths particularly in
sensorimotor cortex and frontal areas. Taking a small (four voxel)
region centred in sensorimotor cortex (S1; bregma coordinates
(3.20 mm left-right, 0.60 mm anterior-posterior, 2.5 mm inferior-
superior) shows significant decreases of 3.5% and 4.0% in R6/2
(CAG 100–200) and R6/2 (CAG 200–300) series mice with p-
values of 0.002 and 0.004. No significant decreases were seen at
this location for R6/2 (CAG 300–400) or the YAC mice (p.0.05).
These p-values were calculated with two-tailed Student’s t-tests
using Matlab 7. These data could be exploited in other ways, for
example in performing voxel-based cortical thickness comparisons
[34] between mouse models or within-group comparisons based
on covariates such as age or sex.
Figure 6 shows the comparison made between MR images and
histology for the closest matching slices between the histological
dataset and native-space image for the same brain including in the
library. It is clear that some shrinkage has occurred in the
histological preparation leading to the histological measurements
being systematically lower than the MRI measurements (though
with good agreement: linear least-squares regression slope 0.91,
R2= 0.94). The agreement between manual MRI-based and
automated MRI-based cortical thickness measurements is better
Figure 1. Steps involved in the evaluation of cortical thickness measures. A: regions of potentials providing boundary conditions for solving
Laplace’s equation (external region (a), cortical regions (b-c), resistive region (d) and internal region (e)) B: the solved potential in the cortex; C:
integration of field lengths to produce D: the thickness map for the cortex shown as a 3D map.
doi:10.1371/journal.pone.0053361.g001
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(regression slope 1.01, R2= 0.99) than the agreement between
manual MRI-based measures and manual histological measures.
Discussion
We are making our extensive collection of high-resolution MR
images of R6/2, YAC128, Cplx1 KO and WT mice publically
available to download in permanence for use for any purpose. This
will be an invaluable resource for the neuroscience and
neuroimaging communities to improve our understanding of the
pathogenesis in HD via study of its morphological phenotype.
In addition to standard computational neuroanatomy tech-
niques (VBM etc.) that we have already applied to subsets from
this library, in this paper we show some of the other ways in which
MRI data can be used to explore differences in transgenic lines
used to model HD. For example, a simple extraction of total
volumes from the GM maps presented here has shown how whole-
brain GM volume shows different age trajectories for the R6/2
lines, adding to mounting evidence of different mechanisms
underlying pathology in mice with ‘super-expanded’ CAG
expansions. Reconstructed cortical thickness maps are an example
of how versatile the images can be and how they are amenable to
a wide range of different analytical treatments with high power
due to the large number of subjects available. We have shown that
the values of cortical thickness obtained by our algorithms are in
good agreement with manual measurements, and that both
measures correspond well with those that would obtained by
images prepared histologically. Since all of the data are now freely
available, it is possible for other users to try alternative algorithms
for cortical thickness measurement.
The range of HD models included in the library show a range of
CAG repeat lengths. There is a growing body of data from
behavioural and gene expression studies suggesting that mice
carrying extremely long CAG repeat lengths show a delayed onset
of phenotype [7,35,36]. The explanation for this delay in onset
remains unclear, since the mice still die prematurely of a neuro-
logical disease [7]. One possibility is that the protein carrying the
very long polyglutamine products of superlong CAG repeat-
containing gene fragments cannot enter the nucleus, and therefore
cannot form the pathological inclusions that are characteristic
Figure 2. Illustrative examples of images from the library. Columns A-B: WT and R6/2 (CAG250) brains. Column C: atlas image for comparison
(see text for details). Columns D-F: in-skull images of WT, R6/2 (CAG250) and YAC128 brains. Horizontal lines in C indicate coronal section positions
(bregma 20.8 mm, 21.5 mm, the horizontal slice is taken at bregma 2.8 mm). Note the damaged areas of the ex-skull brains, for example at the
olfactory bulbs, and the cerebellar tearing.
doi:10.1371/journal.pone.0053361.g002
Figure 3. Native space images from the library for a single brain. Raw data from the scanner (A), grey matter segmented map (B, shown in
red), white matter segmented map (C, shown in green) and voxel-based cortical thickness map (D).
doi:10.1371/journal.pone.0053361.g003
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pathology of mice with shorter repeats. (The pathology in the
superlong CAG repeat mice is slowly developing and typically
extranuclear.) Although there is no direct clinical analogue of
extremely long somatic CAG repeats in patients, nevertheless very
expanded CAG repeats are found in human post mortem brain,
due to somatic instability [37–39]. Interestingly, the mice with
superlong CAG repeats show a more human-like brain pathology
from those with shorter CAG repeats [7]. The significance of these
findings remains to be established, but it is hoped that identified
differences in htt accumulation and their relationship to onset and
progression of illness will suggest appropriate pathways for
therapeutic agents and interventions. The data presented here
show that the delays seen in phenotype for longer repeat include
changes in the morphological phenotype as seen by MRI. Since
one of the major goals of animal models of HD is to study the early
pathology and potential interventions, the demonstration of
changes in MRI phenotype is important particularly as MRI
findings are increasingly used to monitor disease onset in patients
[40,41].
Large datasets better capture background variability and allow
more subtle effects to be characterized. It is our intention to add
files to the library as we continue to acquire more images from
mice with different CAG expansions so that the various patterns of
disease seen can be studied in depth. In addition, we plan to add
our in vivo acquisitions to extend this resource. There is no
comparable library of publically-available mouse brain datasets
available and we hope that our publication will encourage other
Figure 4. GM volumes for brains from the library. A linear fit to the WT brains (solid line) showing two standard deviations above and below
(dashed lines) is repeated on each graph to aid comparison. For the R6/2 lines these data clearly show different age trajectories for different CAG
repeats.
doi:10.1371/journal.pone.0053361.g004
Figure 5. Reconstructed cortex images showing cortical thickness for brains from the library, scale bar in mm.
doi:10.1371/journal.pone.0053361.g005
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investigators to make their data available to provide new
opportunities for insight into neurodegenerative disease.
We are committed to open-source software and free access to
data and in addition to the online database we will share the
algorithms used in this manuscript with other users on request.
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